MedNet.nl: One-quarter to one-third of patients with severe eosinophilic asthma who do not achieve clinical remission after 1 year of treatment with benralizumab still achieve remission in the second year of treatment. In patients who do achieve remission in the first year, over three-quarters maintain remission in the second year as well.
25-09-2023 | Bronchial Asthma | News
ERS 2023